The Legislative Yuan yesterday passed an amendment to the Pharmaceutical Affairs Act (藥事法), which includes increased punishments for manufacturing or importing counterfeit or banned drugs.
The Food and Drug Administration (FDA) said that the amendment aims to increase the liability of pharmaceutical companies and establish a tracing mechanism to report drug shortages, as well as improving drug use instructions to better inform the patients, while creating a mechanism for emergency manufacturing or imports of drugs and better drug source management.
Before the amendment, pharmaceutical companies or people who produced or imported counterfeit or banned drugs faced a maximum fine of NT$10 million (US$303,260) and a maximum jail term of 10 years.
The amendment increased the maximum fine to NT$100 million, but it can climb as high as NT$200 million if the drugs cause any deaths, while prison terms remain unchanged.
As for drugs that fail to meet standards imposed by authorities, the companies that manufacture or import them are to face fines ranging between NT$100,000 and NT$5 million — a significant rise from the previously enforced fines ranging between NT$60,000 and NT$300,000 — as well as the confiscation of any illegal gains from sale of the drugs.
Moreover, if pharmaceutical companies find it difficult to continue supplying necessary drugs designated by the government for any reason, they are to report to the authorities within six months, or at least 30 days if the supply interruption is caused by a natural disaster or accident.
Regarding an article of the amendment that requires the clarification of drug use instructions for easier understanding, the Taiwan Healthcare Reform Foundation urged the FDA to set a schedule for enforcing a reform of drug package labeling and instructions, saying the reform should begin with over-the-counter drugs.
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
The Ministry of Finance this afternoon announced the winning numbers for the March-April uniform invoice lottery. The winning number for the NT$10 million (US$318,060) special prize is 19531471, and the winning number for the NT$2 million grand prize is 85941329. Three numbers were drawn for the NT$200,000 first prize: 07225810, 20231230 and 83518781. Those with receipts matching the last seven digits of any of the first-prize numbers will win the NT$40,000 second prize, while those matching the last six digits will win the NT$10,000 third prize. Those whose receipts match the last five digits of the first-prize numbers can claim the NT$4,000 fourth prize,
Taiwan Travelogue (臺灣漫遊錄), which earlier this week became the first Taiwanese novel to win the International Booker Prize, is to be adapted into a television series through a Taiwan-Japan coproduction, producer Chang Chen-yu (張辰漁) said yesterday. Chang, a producer at World Softest Production Film Co, wrote on Facebook that the company had been searching for projects with international appeal that retain a strong Taiwanese identity after colleagues and Japanese partners strongly recommended the novel. After reading the book, Chang said he immediately decided to pursue the screen rights. “A great story has the power to transcend time and borders, and connect countless people,”